[Annual Reports in Medicinal Chemistry] Annual Reports in Medicinal Chemistry Volume 3 Volume 3 || Chapter 33. Physicochemical Parameters in Drug DesignHansch, Corwin · 1968

[Annual Reports in Medicinal Chemistry] Volume 33 || Copyright, · 1998

[Annual Reports in Medicinal Chemistry] Volume 33 || Contributors, · 1998

[Annual Reports in Medicinal Chemistry] Volume 5 || Chapter 33. Reactions of Interest in Medicinal ChemistryWiley, Robert A. · 1970

[Annual Reports in Medicinal Chemistry] Volume 33 || AdenosineDeNinno, Michael P. · 1998

[Annual Reports in Medicinal Chemistry] Volume 33 || PrefaceBristol, James A. · 1998

[Annual Reports in Medicinal Chemistry] Volume 30 || Chapter 33. Educating Medicinal ChemistsGanellin, C. Robin · 1995

[Annual Reports in Medicinal Chemistry] Volume 33 || Series Page, · 1998

ICE viewpointDouglas K. Miller; David A. Giegel · 1997

ICE processing and kinetic mechanismDavid A. Giegel · 1997

Replacement of ethanolamine phosphate by 3-aminopropylphosphonate in the phospholipids of TetrahymenaJoseph Donald Smith; David A. Giegel · 1981

Cloning, Tissue Expression and Regulation of Rat Interleukin 1β Converting EnzymeKaren M. Keane; David A. Giegel; William J. Lipinski; Michael J. Callahan; Brenda D. Shivers · 1995

Effect of a phosphonic acid analog of choline phosphate on phospholipid metabolism in TetrahymenaJoseph Donald Smith; David A. Giegel · 1982

A catalytic mechanism for caspase-1 and for bimodal inhibition of caspase-1 by activated aspartic ketonesKenneth D. Brady; David A. Giegel; Christine Grinnell; Elizabeth Lunney; Robert V. Talanian; Winnie Wong; Nigel Walker · 1999

Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9ANNAND, Robert R.; DAHLEN, Jeffrey R.; SPRECHER, Cindy A.; DE DREU, Piet; FOSTER, Donald C.; MANKOVICH, John A.; TALANIAN, Robert V.; KISIEL, Walter; GIEGEL, David A. · Biochemical Journal · 1999